论文部分内容阅读
目的:初探帕金森患者脑脊液诊断生物标志物研究。方法:通过阐述帕金森患者的临床症状,对该疾病的病情进行分析,引出该病的发病机制和诊断方式,并聚焦帕金森病患者脑脊液诊断生物标志物的研究。结果:患者在接受治疗时,通常会出现中断的现象,大多都是不能得到很好地控制,病情会出现反复发作的现象。通常发展到晚期的患者才开始接受治疗时,病情已经发展的很严重,目前现有的医疗设备也很难在对病情进行改善,患者通常都会比较明显的运动和神经障碍。结论:帕金森患者脑脊液诊断生物标志物对帕金森患者的诊断具有一定的研究价值。
Objective: To study the diagnostic biomarkers of cerebrospinal fluid in Parkinson’s patients. Methods: By analyzing the clinical symptoms of Parkinson’s disease patients, the disease’s condition was analyzed, the pathogenesis and diagnosis of the disease were elicited, and the biomarkers of cerebrospinal fluid in patients with Parkinson’s disease were focused. Results: The patients usually experienced disruption when they were receiving treatment. Most of them were unable to be well controlled and their condition experienced repeated attacks. Patients usually develop late to start treatment, the condition has developed very serious, the current existing medical equipment is also difficult to improve the condition, the patient will usually be more obvious movement and neurological disorders. Conclusions: Cerebrospinal fluid biomarkers of Parkinson’s disease have some value in the diagnosis of Parkinson’s disease.